HC Wainwright Reaffirms Buy Rating for Western Copper & Gold (NYSE:WRN)
HC Wainwright restated their buy rating on shares of Western Copper & Gold (NYSE:WRN – Free Report) in a research report released on Tuesday morning,Benzinga reports. The firm currently has a $4.25 ...
Vanda Pharmaceuticals (NASDAQ:VNDA) Given New $20.00 Price Target at HC Wainwright
Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) had its price target upped by HC Wainwright from $18.00 to $20.00 in a research note issued to investors on Tuesday morning,Benzinga reports. HC ...
H.C. Wainwright Sticks to Its Buy Rating for Anixa Biosciences (ANIX)
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Anixa Biosciences (ANIX – Research Report) on February 14 and set a price target of ...
H.C. Wainwright Sticks to Its Buy Rating for Hecla Mining Company (HL)
H.C. Wainwright analyst Heiko Ihle reiterated a Buy rating on Hecla Mining Company (HL – Research Report) today and set a price target of ...
H.C. Wainwright cuts Compass Pathways stock target to $45
H.C. Wainwright analyst Patrick Trucchio revised the price target on Compass Pathways (NASDAQ:CMPS) stock, reducing it to $45 ...
Investing14d
H.C. Wainwright maintains buy on Northern Dynasty stock
Tuesday, H.C. Wainwright reaffirmed its Buy rating on Northern Dynasty Minerals (NYSE:NAK) with a steady price target of $1.30, representing significant upside from the current trading price of $0.65.
Nasdaq15d
HC Wainwright & Co. Initiates Coverage of CRISPR Therapeutics (BRSE:1CG) with Buy Recommendation
Fintel reports that on February 3, 2025, HC Wainwright & Co. initiated coverage of CRISPR Therapeutics (BRSE:1CG) with a Buy recommendation. There are 575 funds or institutions reporting positions ...
Insider Monkey16d
Knightscope, Inc. (KSCP) Receives ‘Buy’ Rating from H.C. Wainwright with $16 Target
On January 31, the company announced that H.C. Wainwright & Co. has initiated coverage on it with a “Buy” rating and a 12-month price target of $16 per share. The report highlights several ...